Highlights from the 2024 Alliance for Clinical Trials in Oncology Fall Meeting
The 2024 Alliance for Clinical Trials in Oncology Fall Meeting took place from October 30th to November 1st at Loews Chicago O’Hare Hotel.
The meeting brought together oncology professionals to discuss advancements in clinical research. Alliance for Clinical Trials in Oncology fall meeting featured a series of presentations highlighting ongoing clinical trials, innovative methodologies, and recent findings in cancer treatment.
Keynote speakers shared insights on the latest trends in oncology, while breakout sessions allowed for in-depth discussions on specific topics such as personalized medicine and data analytics in clinical trials. Networking opportunities facilitated collaborations among researchers, clinicians, and industry partners.
Healthcare professionals and organisations shared their insights on social media:
Alliance for Clinical Trials in Oncology:
“The Alliance for Clinical Trials in Oncology Patient Advocate Committee, chaired by Patty Spears with vice-chairs Vernal Branch and Jane Perlmutter, convened a robust meeting at the 2024 Alliance Fall Hybrid Group Meeting.”
“Wonderful Alliance for Clinical Trials in Oncology symptom intervention committee with speakers Elad Sharon and Ting Bao and many exciting new concepts.”
“Getting to hear from our valued alumnus from Alliance for Clinical Trials in Oncology, currently the Monica M. Bertagnolli! So exciting to hear from one of the most innovative and dynamic public health leaders our nation has ever had!
“Dr. Tianster Zhang with kidney trial updates at Alliance for Clinical Trials in Oncology Fall 24 meeting, highlighting the STRIKE trial (adjuvant Tivozanib, Pembrolizumab) getting close to activation and the PDIGREE trial now completed accrual!”
“A great first Alliance Fall 2024 meeting as GU junior faculty. Looking forward to ongoing discussions and continued connections with new colleagues and friends!”
Alliance for Clinical Trials in Oncology:
“Congratulations, Monica M. Bertagnolli, MD (Director, National Institutes of Health) for receiving the 2024 Charles G. Moertel Award at the 2024 Alliance Fall Hybrid Group Meeting!”
“Honored to present our Integrative Medicine for chemotherapy-induced peripheral neuropathy research projects at Alliance for Clinical Trials in Oncology conference in Chicago. Thanks Maryam Lustberg, Kathryn Ruddy.”
“Dr. Apolo Andrea giving bladder trial updates including AMBASSADOR showing DFS benefit of adjuvant pembrolizumab in high risk MIUC at ALLIANCE Fall 2024.”
“Thanks for highlighting Qian Janie Qin!
Alliance for Clinical Trials in Oncology kidney cancer trial portfolio is strong. Great to see launching of STRIKE in adjuvant setting, steady enrollment on RADICAL, PDIGREE in follow up.
UTSW Simmons Cancer Center has contributed to many of current RCC trials!
Alliance for Clinical Trials in Oncology:
“It’s a wrap on an exciting three-day meeting! THANK YOU to everyone participating in the 2024 Alliance Fall Hybrid Group Meeting. Your remarkable efforts continue to advance cancer research. See you again next spring – Apr 30-May 3.”
More posts featuring Alliance for Clinical Trials in Oncology
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023